MAPK8 and obesity disorder: In this report, we employed compound SR3306 and SR11935, novel JNK inhibitors that are selective, water-soluble and brain-penetrant17, 18, to investigate the roles of JNK in the control of feeding and energy balance as well as in the development of obesity.